Experimental Drug Development Center
Shanghai’s Everest Medicines Licenses COVID-19 Oral Antivirals from Singapore’s National Drug Discovery Platform
2022-01-17
The Rise of Asia as a Destination of Biotech Investment and Opportunity
2020-07-27Partner